The pursuit of relevance in interaction and networks research

The paper investigates the perceptions of researchers working in interaction and networks research concerning the relevance of academic research in the field to practical management decision-making. Managerial relevance was defined along five dimensions – level of interest, potential practical value, lead-time, development required, and overall relevance. Perceptions of relevance were measured using a face-to-face questionnaire administered to researchers in the field. The perceived relevance of their own work and of work presented at the 15th IMP conference were measured. A “relevance gap” was identified, with researchers perceiving their own work to be of much greater practical relevance than the conference proceedings. Hypotheses to explain differences in perceptions of relevance are tested. Implications for the research agenda are considered, in terms of making research more relevant, and communicating more effectively with managersFinal Accepted Versio

Fourteenth annual report of the Power Affiliates Program.

Includes bibliographical references

Eighteenth annual report of the Power Affiliates Program.

Includes bibliographical references

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

BACKGROUND: Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving limited insights into mucosal defences that prevent viral replication and onward transmission. We studied nasal and plasma antibody responses one year after hospitalisation for COVID-19, including a period when SARS-CoV-2 vaccination was introduced. METHODS: In this follow up study, plasma and nasosorption samples were prospectively collected from 446 adults hospitalised for COVID-19 between February 2020 and March 2021 via the ISARIC4C and PHOSP-COVID consortia. IgA and IgG responses to NP and S of ancestral SARS-CoV-2, Delta and Omicron (BA.1) variants were measured by electrochemiluminescence and compared with plasma neutralisation data. FINDINGS: Strong and consistent nasal anti-NP and anti-S IgA responses were demonstrated, which remained elevated for nine months (p < 0.0001). Nasal and plasma anti-S IgG remained elevated for at least 12 months (p < 0.0001) with plasma neutralising titres that were raised against all variants compared to controls (p < 0.0001). Of 323 with complete data, 307 were vaccinated between 6 and 12 months; coinciding with rises in nasal and plasma IgA and IgG anti-S titres for all SARS-CoV-2 variants, although the change in nasal IgA was minimal (1.46-fold change after 10 months, p = 0.011) and the median remained below the positive threshold determined by pre-pandemic controls. Samples 12 months after admission showed no association between nasal IgA and plasma IgG anti-S responses (R = 0.05, p = 0.18), indicating that nasal IgA responses are distinct from those in plasma and minimally boosted by vaccination. INTERPRETATION: The decline in nasal IgA responses 9 months after infection and minimal impact of subsequent vaccination may explain the lack of long-lasting nasal defence against reinfection and the limited effects of vaccination on transmission. These findings highlight the need to develop vaccines that enhance nasal immunity. FUNDING: This study has been supported by ISARIC4C and PHOSP-COVID consortia. ISARIC4C is supported by grants from the National Institute for Health and Care Research and the Medical Research Council. Liverpool Experimental Cancer Medicine Centre provided infrastructure support for this research. The PHOSP-COVD study is jointly funded by UK Research and Innovation and National Institute of Health and Care Research. The funders were not involved in the study design, interpretation of data or the writing of this manuscript

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged symptoms termed long coronavirus disease (COVID), yet disease phenotypes and mechanisms are poorly understood1. Here we profiled 368 plasma proteins in 657 participants ≥3 months following hospitalization. Of these, 426 had at least one long COVID symptom and 233 had fully recovered. Elevated markers of myeloid inflammation and complement activation were associated with long COVID. IL-1R2, MATN2 and COLEC12 were associated with cardiorespiratory symptoms, fatigue and anxiety/depression; MATN2, CSF3 and C1QA were elevated in gastrointestinal symptoms and C1QA was elevated in cognitive impairment. Additional markers of alterations in nerve tissue repair (SPON-1 and NFASC) were elevated in those with cognitive impairment and SCG3, suggestive of brain–gut axis disturbance, was elevated in gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2-specific immunoglobulin G (IgG) was persistently elevated in some individuals with long COVID, but virus was not detected in sputum. Analysis of inflammatory markers in nasal fluids showed no association with symptoms. Our study aimed to understand inflammatory processes that underlie long COVID and was not designed for biomarker discovery. Our findings suggest that specific inflammatory pathways related to tissue damage are implicated in subtypes of long COVID, which might be targeted in future therapeutic trials

Applicability of the polyphenylene oxide film dosimeter to high UV exposures in aquatic environments

Previous research has proven that the Poly (2,6-dimethyl-1, 4-phenylene oxide) (PPO) dosimeter is capable of receiving both in-air and underwater UV exposures that are significantly greater than those of the more commonly used polysulphone dosimeter, within a range of accuracy close to what would be expected of dosimetric measurements made in-air provided that the necessary calibrations are completed correctly by factoring in different atmospheric column ozone levels, SZA ranges, varying water turbidity and DOM levels. However, there is yet to be an investigation detailing the performance of the PPO dosimeter and its ability to measure UV in an actual field environment over an extended period of time. This research aims to bridge this gap in the knowledge by presenting a measurement campaign carried out in two real world aquatic environments and a simulated sea water environment using a batch of PPO dosimeters set at different depths and aligned to a range of different angles and geographical directions by means of attachment to a custom built dosimeter submersible float (DSF) unit over the space of a year at a sub-tropical location. Results obtained from this measurement campaign were used to compute a Kd value for the sea water in each particular season. These Kd values where found to be in close agreement to standalone Kd values derived from results taken using a standard calibrated spectrometer in the same sea water

Customer confusion The mobile phone market

SIGLEAvailable from British Library Document Supply Centre-DSC:9104.3104(99/07) / BLDSC - British Library Document Supply CentreGBUnited Kingdo

Twentieth annual report of the Power Affiliates Program.

Includes bibliographical references

Fifteenth annual report of the Power Affiliates Program.

Includes bibliographical references

Nineteenth annual report of the Power Affiliates Program.

Includes bibliographical references